RSS Feed This entry was posted on Tuesday, November 25th, 2008 at 9:42 am and is filed under FYI. You can leave a response, or trackback from your own site.
 |
- At Other Sites
- Beam Me Up
- Book Review
- Breaking News
- CBO
- Discussion
- From the Trenches
- FYI
- Ground Control to Sen. Democrats
- Health Alert
- 2008 Election
- African AIDS
- Babies
- Bad Studies
- Book Reviews
- Bush Health Plan
- Diabetics
- Drugs
- Health Care Access
- Health Care Costs
- Health Reform
- HSAs
- International
- LAZIK Surgery
- Malpractice
- Media Advisory
- Medicaid
- Medical Economics
- Medical Tourism
- Mental Health
- Minimum Wage
- Portability
- Racial Disparities
- RAND Studies
- Safety
- Scary Forecasts
- SCHIP
- Seniors/Medicare
- Socialized Medicine
- Supply Side
- Telemedicine
- Transparency
- Uninsured
- Vet Care
- Vision Thing
- Workers Comp
- Hits & Misses
- Holiday
- In Memoriam
- In the News
- Interesting Videos
- Memorial Day
- New Videos
- NHS Update
- Notable and Quotable
- Obesity Update
- On Capitol Hill
- Personal Testimony
- Petition
- Plans
- Policy Update
- Question of the Week
- Quote of the Day
- Season's Greetings
- Song of the Season
- The People Speak Out
- Updates
Categories
Contributors
- Ron Bachman
- Michael Bond
- Jim Frogue
- John Goodman
- Linda Gorman
- Robert Graboyes
- John R. Graham
- Devon Herrick
- Regina Herzlinger
- June O'Neill
- Roy Ramthun
- Greg Scandlen
Recent Posts
- The Truly Bizarre Structure of ObamaCare Health Care Subsidies
- The Callahan Solution for Spiraling Health Costs: Put Seniors on the Ice
- Maybe Sen. Bunning is Right about Unemployment Benefits
- The Mystery of Health Care Policy
- Insurance Regulators Push Back on White House Demagoguery
- Half of All Infections are Caused by Hospitals, Household Dust, and Kids are Snacking More
- White House Endorses High Deductible Health Insurance
- A Strange Way to Look at Health Economics
- Deadliest State for Bicyclists, One Less Cookie, and Is Sugar Safe?
- Why the Antitrust Exemption Matters
Blogroll
Nov 25, 2008
Almost $200 million over four years, and to read the media accounts you would think this is a bad thing. I suspect it is a good thing – for the patients and for the taxpayers. Aspirin was never approved by the FDA and many experts think that under today's ridiculous rules it probably couldn't pass. [link]
2 Responses to “Unapproved Drugs in Medicaid”
RSS
Twitter
YouTube
LinkedIn
Facebook
Flickr
Helium
November 25th, 2008 at 11:31 am
Right on!!!
The reason doctors prescribe these older (grandfathered) drugs is because they work.
November 25th, 2008 at 11:57 am
I agree with Greg. Medicaid patients are lucky the FDA hasn’t decided to approve the older drugs.
The FDA is not pro-patient. It is pro-nanny-state- order-everyone-around-and-tell-them-what-to-do.